Kindler HL, Hammel P, Michele Reni, et al. Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. ASCO Annual Meeting 2019, abstract LBA4.
Olaparib plus bevacizumab bij ovariumcarcinoom: definitieve OS-resultaten van PAOLA-1
aug 2023 | Gynaecologische oncologie